India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
Gastric is a growing health problem of Nepali society Gastric is called 'gastritis' in medical language. Its main cause is infection with the H. pylori bacteria. In fact, gastritis itself is not a disease, it is just a stomach problem. Gastric is a common problem for most Nepalis, the main cause of gastritis is poor or unbalanced diet. It involves an infection of the inner part of the stomach, which causes the inner lining of the stomach (mucosa) to swell. Gastritis can cause ulcers to form on the inside of the stomach, which can even lead to cancer in serious cases. The main cause of this is infection with the H. pylori bacteria. This problem is caused by many reasons such as not eating on time, staying hungry for a long time, stressful routine, eating too much greasy, fried and fried food, eating food that the body cannot digest, and not exercising. Gastric symptoms - Feeling of burning in the upper abdomen or stomach - Pain or discomfort around the chest and stomach cavity ...